Has The Slide In Procore Technologies (PCOR) Opened A Better Long Term Entry Point?

  • Wondering if Procore Technologies at around US$42.20 still lines up with what you think it is worth, or if the recent weakness has opened up a better entry point.
  • The stock is down 16.8% over the past week, 12.2% over the past month, and 39.7% year to date, with a 35.4% decline over the last year and 37.9% and 50.3% falls over the past three and five years.
  • Recent coverage has focused on Procore Technologies as a construction software platform and how sentiment around growth software stocks has been shifting. This has kept attention on valuations, profitability paths, and competitive positioning. These themes help frame why the share price has been under pressure and why investors are rechecking what they are willing to pay for future cash flows.
  • On Simply Wall St's 6 point valuation checklist, Procore Technologies scores a 5. The rest of this article will walk through what different valuation approaches say about the stock and finish with a framework that can help you judge value more clearly.

Find out why Procore Technologies's -35.4% return over the last year is lagging behind its peers.

Advertisement

Approach 1: Procore Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes expected future cash flows, discounts them back to today using a required rate of return, and sums them to estimate what the business might be worth right now.

For Procore Technologies, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $199.4 million. Analyst and extrapolated estimates used in the model project free cash flow reaching $639.7 million by 2030, with intermediate annual figures between 2026 and 2035 all below $1 billion and expressed in millions of dollars.

Pulling those projected cash flows together, Simply Wall St’s DCF output points to an estimated intrinsic value of $81.28 per share. Compared with a current share price of around $42.20, this implies the stock is trading at a 48.1% discount to this model’s estimate of value, which suggests the shares are undervalued on these assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Procore Technologies is undervalued by 48.1%. Track this in your watchlist or portfolio, or discover 46 more high quality undervalued stocks.

PCOR Discounted Cash Flow as at Jun 2026
PCOR Discounted Cash Flow as at Jun 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Procore Technologies.

Approach 2: Procore Technologies Price vs Sales

For many software companies that are not yet focused on bottom line earnings, the Price to Sales, or P/S, ratio is often more practical than P/E because it compares the company’s market value with the revenue it is already generating. Investors usually accept a higher P/S when they expect stronger revenue growth or lower business risk, and a lower P/S when growth expectations or confidence are weaker.

Procore Technologies currently trades on a P/S of 4.64x. This sits above the broader Software industry average of 3.41x, but below the peer group average of 5.84x. Simply Wall St’s Fair Ratio for Procore Technologies is 5.52x. This is the P/S level that its model suggests could be reasonable given factors such as the company’s growth profile, profit margins, industry, market cap and risk characteristics.

The Fair Ratio can be more useful than a simple peer or industry comparison because it adjusts for those company specific features that can skew basic multiples. Comparing the Fair Ratio of 5.52x with the current P/S of 4.64x indicates that Procore Technologies is trading below that model-based reference point on this measure.

Result: UNDERVALUED

NYSE:PCOR P/S Ratio as at Jun 2026
NYSE:PCOR P/S Ratio as at Jun 2026

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Procore Technologies Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story to your numbers by linking your view of Procore Technologies, your revenue, earnings and margin assumptions, and your fair value into a single forecast that you can compare with the current share price. This can help you decide if you see the stock as attractive or expensive. Each Narrative updates automatically as new earnings or news arrives and can result in very different fair values, such as around US$95.00 at the bullish end and about US$55.00 at the cautious end. Both of these are visible on the Community page used by millions of investors.

Do you think there's more to the story for Procore Technologies? Head over to our Community to see what others are saying!

NYSE:PCOR 1-Year Stock Price Chart
NYSE:PCOR 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:PCOR

Procore Technologies

Provides a cloud-based construction management platform and related products and services in the United States and internationally.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
186 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0